John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCOY
2226
Decoy Therapeutics
DCOY
$2.04M
| – | – |
0
| – | – |
|
|
AVGR
2227
DELISTED
Avinger, Inc. Common Stock
AVGR
| – | – |
0
| – | – |
|
2228
Interface
TILE
$2.21B
| $309K | ﹤0.01% |
16,140
-172,155
| -91% | -$3.55M |
|
|
PRSU
2229
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
| $309K | ﹤0.01% |
+10,946
| New | +$334K |
|
|
STJ
2230
PUT
DELISTED
St Jude Medical
STJ
| $309K | ﹤0.01% |
+5,000
| New | +$315K |
|
|
LNCO
2231
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
| $309K | ﹤0.01% |
+303,355
| New | +$613K |
|
2232
CALL
Ashland
ASH
$3.38B
| $308K | ﹤0.01% |
+6,132
| New | +$323K |
|
|
ESV
2233
CALL
DELISTED
Ensco Rowan plc
ESV
| $308K | ﹤0.01% |
5,000
+1,250
| +33% | +$81.7K |
|
2234
CALL
A.O. Smith
AOS
$8.52B
| $306K | ﹤0.01% |
+8,000
| New | +$302K |
|
|
ABB
2235
DELISTED
ABB Ltd
ABB
| $306K | ﹤0.01% |
17,252
-82,376
| -83% | -$1.52M |
|
|
DSPG
2236
DELISTED
DSP Group Inc
DSPG
| $303K | ﹤0.01% |
32,105
-22,478
| -41% | -$221K |
|
2237
CALL
Eagle Materials
EXP
$6.27B
| $302K | ﹤0.01% |
+5,000
| New | +$333K |
|
2238
JD.com
JD
$39.4B
| $301K | ﹤0.01% |
+9,318
| New | +$275K |
|
2239
Commercial Vehicle Group
CVGI
$124M
| $300K | ﹤0.01% |
+108,739
| New | +$391K |
|
2240
CALL
Prologis
PLD
$136B
| $300K | ﹤0.01% |
+7,000
| New | +$295K |
|
|
CAA
2241
DELISTED
CalAtlantic Group, Inc.
CAA
| $300K | ﹤0.01% |
+7,920
| New | +$317K |
|
|
ALX
2242
Alexander's
ALX
$1.38B
| $297K | ﹤0.01% |
772
-200
| -21% | -$77.4K |
|
2243
Caesarstone
CSTE
$118M
| $295K | ﹤0.01% |
6,800
-3,800
| -36% | -$145K |
|
2244
ICL Group
ICL
$7.42B
| $295K | ﹤0.01% |
+72,734
| New | +$365K |
|
2245
CALL
Healthpeak Properties
DOC
$14.9B
| $294K | ﹤0.01% |
8,455
-20,093
| -70% | -$672K |
|
2246
Enbridge
ENB
$109B
| $294K | ﹤0.01% |
+8,837
| New | +$332K |
|
2247
CALL
The Greenbrier Companies
GBX
$1.43B
| $294K | ﹤0.01% |
+9,000
| New | +$309K |
|
2248
Halozyme
HALO
$12.3B
| $294K | ﹤0.01% |
16,961
-193,758
| -92% | -$3.09M |
|
2249
CALL
Jacobs Solutions
J
$17.7B
| $294K | ﹤0.01% |
+8,463
| New | +$290K |
|
|
HTBK
2250
DELISTED
Heritage Commerce
HTBK
| $293K | ﹤0.01% |
+24,510
| New | +$270K |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.